[财迷]
Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
LEXINGTON, Mass., Feb. 11, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage bio
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
4
举报
登录后可参与评论
![empty](https://c1.itigergrowtha.com/community/assets/media/empty-default.06ba11e0.png)
暂无评论